Defunct Company
Total Trials
13
As Lead Sponsor
2
As Collaborator
11
Total Enrollment
841
NCT04106817
Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 19, 2015
Completion: Aug 10, 2015
NCT02418767
Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers
Role: Collaborator
Start: Jan 31, 2015
Completion: Jun 30, 2015
NCT02566252
Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)
Start: Jul 31, 2015
Completion: Mar 31, 2016
NCT02537938
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)
Start: Jan 31, 2016
Completion: Dec 31, 2016
NCT02803996
Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers
Start: May 31, 2016
NCT02801903
Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris
Start: Jun 7, 2016
Completion: Aug 25, 2016
NCT03053635
Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients
Start: Dec 21, 2016
Completion: Aug 9, 2018
NCT03307512
PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD
Phase: Phase 2
Start: Feb 6, 2018
Completion: Aug 30, 2019
NCT03721549
Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model
Start: Oct 3, 2018
Completion: Nov 28, 2018
NCT04043169
Clearblue Pregnancy Test - Lay User Study
Phase: N/A
Start: Jul 30, 2019
Completion: Dec 31, 2019
NCT04625595
Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes
Start: Nov 9, 2020
Completion: Jul 31, 2021
NCT04746014
Clearblue Pregnancy Test Lay User Usage Study
Start: Feb 9, 2021
Completion: Aug 3, 2021
NCT04783090
MT1013 Clinical TRIAL In Healthy Subject
Start: Jun 28, 2021
Completion: Mar 17, 2022